When should I use the HCV Fibrosis APRI?

Use the HCV Fibrosis APRI when you need a structured infectious-disease assessment to support bedside triage, escalation, or follow-up decisions. It should complement, not replace, clinical judgement and local guideline pathways.

Does the HCV Fibrosis APRI replace specialist review?

No. The HCV Fibrosis APRI helps standardize risk assessment and communication, but specialist input, microbiology data, imaging, and patient trajectory still drive final management.

HCV Fibrosis APRI Calculator | Infectious Disease Tool

CLINICAL REFERENCE

CLINICAL INSIGHT

When to Use

Use during early bedside triage when infection severity or treatment escalation is uncertain.
Support clinician judgement with a structured review of the highest-yield risk factors.
Standardise communication between admitting, ID, ICU, and pharmacy teams.

CLINICAL INSIGHT

How it Works

Scoring Logic

AST above upper limit of normal (+2)
Platelets <150 ×10⁹/L (+2)
Portal hypertension features (+2)
Low albumin / synthetic dysfunction (+1)
Splenomegaly (+1)
Jaundice or decompensation history (+2)

CLINICAL INSIGHT

Next Steps

Clinical Actions

Interpret the result together with source control, microbiology, host factors, and trajectory.
Escalate imaging, cultures, or specialist review when the tool lands in a high-risk tier.
Reassess dynamically if the patient deteriorates or new microbiology becomes available.

CLINICAL INSIGHT

Practical Pearls

Important Caveat

This tool supports structured infectious-disease decision making but does not replace clinician judgement or local guideline pathways.

CLINICAL INSIGHT

Evidence Base

This OpiCalc infectious-disease entry reflects commonly used guideline criteria and bedside risk features used in contemporary clinical practice.

When to Use

When to Use

How it Works

Scoring Logic

Next Steps

Clinical Actions

Practical Pearls

Important Caveat

Evidence Base

Evidence Base

HCV Fibrosis APRI

Lower Risk

When to Use

When to Use

How it Works

Scoring Logic

Next Steps

Clinical Actions

Practical Pearls

Important Caveat

Evidence Base

Evidence Base

HCV Fibrosis APRI

Lower Risk

Clinical Evidence and Methodology

When to Use

When to Use

How it Works

Scoring Logic

Next Steps

Clinical Actions

Practical Pearls

Important Caveat

Evidence Base

Evidence Base

HCV Fibrosis APRI

Lower Risk

Clinical Evidence and Methodology

When to Use

When to Use

How it Works

Scoring Logic

Next Steps

Clinical Actions

Practical Pearls

Important Caveat

Evidence Base

Evidence Base

HCV Fibrosis APRI

Lower Risk